Xtentus Ltd. commercializes TRATEK, ai-one™ powered financial platform

Zurich, Switzerland – July 15, 2009 – Semantic system ag announced  today that it signed an exclusive agreement with Xtentus Ltd. that buy fluconazole will allow Xtentus the rights to develop, use, and market TRATEK, a financial trading platform that is based on semantic system’s ai-one™ powered Graphalizer product.

Walter Diggelmann, CEO of semantic system ag said that he is “very excited about having a partner that can help take this product to the next level with Xtentus’ proven experience in financial systems and computational models.”

TRATEK enables financial experts to supplement their trading platforms by allowing them to look at developing relationships in a real time scenario that will extrapolate from existing data in order to create more accurate and effective financial models.

About Xtentus
Xtentus Ltd. is an independent Swiss-based alternative investment asset management firm that specializes in Fund Management and global Portfolio Account Management for institutions and high net worth individuals. Xtentus is fully licensed and regulated as a member of the FQA (Financial Services Quality Assurances Association, No. 12370), which is the largest official self-regulation organization created in accordance with the Swiss Federal Financial Administration acknowledged GwG (Money Laundering Law).

To view the entire press release please click here: Press Release July 15 2009 – semantic system signs agreement with Xtentus Ltd.

Comments are closed.